Complications of Uncontrolled Diabetes: Multisystem Pathophysiology and Prevention
Chronic hyperglycemia drives microvascular and macrovascular complications through shared pathogenic pathways: advanced glycation end-products (AGEs), polyol pathway flux, PKC activation, hexosamine pathway, and oxidative stress.
Microvascular Complications
- Retinopathy: Non-proliferative (microaneurysms, dot-blot hemorrhages, hard exudates) → proliferative (neovascularization, vitreous hemorrhage, tractional retinal detachment). Leading cause of blindness in working-age adults. Screening: Annual dilated exam (Type 1: 5yr post-dx; Type 2: at dx).
- Nephropathy: Hyperfiltration → microalbuminuria (30-300 mg/g Cr) → macroalbuminuria (>300) → declining GFR → ESRD. ACEi/ARB first-line for albuminuria + BP control.
- Neuropathy: Distal symmetric polyneuropathy (stocking-glove), autonomic (gastroparesis, orthostatic hypotension, ED, neurogenic bladder), mononeuropathies. Screen annually (monofilament, vibration, symptoms).
Macrovascular Complications
- ASCVD: 2-4x risk MI, stroke, PAD. Mechanisms: endothelial dysfunction, accelerated atherosclerosis, prothrombotic state. Statin indicated for most >40yo.
- Heart failure: Diabetic cardiomyopathy (diastolic dysfunction, fibrosis) independent of CAD.
Other Complications
- Skin: Necrobiosis lipoidica, diabetic dermopathy, acanthosis nigricans, infections (fungal, bacterial), delayed wound healing
- Dental: Periodontitis (bidirectional with glycemic control)
- Sexual: ED (men: 3x risk), female sexual dysfunction
- Pregnancy: GDM → macrosomia, shoulder dystocia, neonatal hypoglycemia, congenital anomalies (preconception HbA1c <6.5%)
- Cognitive: Accelerated decline, vascular dementia, Alzheimer's link
- Infections: Impaired neutrophil function; mucormycosis (DKA), emphysematous pyelonephritis
Prevention Framework (ADA Standards of Care)
- Glycemic targets: HbA1c <7% individualized; TIR >70% (CGM)
- BP control: <130/80 mmHg
- Lipids: High-intensity statin for 40-75yo; LDL <70 (ASCVD), <55 (very high risk)
- Antiplatelet: Aspirin 75-162mg for secondary prevention; select primary
- SGLT2i/GLP-1 RA: Cardiorenal benefits independent of glucose
- Screening schedule: Eye, foot, kidney, neuropathy annually
- Lifestyle: Mediterranean/DASH diet, 150 min/week activity, smoking cessation, weight management
Multidisciplinary care (endo, PCP, ophthalmology, podiatry, nephrology, cardiology, diabetes education) reduces complication incidence by 50-70% in trial settings.
Diabetes - Related Articles
- Diabetic Neuropathy: Symptoms, Causes & Management
- Hypoglycemia Nursing Diagnosis: Understanding & Management
- Sugar-Restricted Diets: Benefits, Causes & Considerations
- Seroquel and Diabetes: Understanding the Risk
- Understanding Elevated Blood Sugar: Causes & Management
- Managing Diabetic Neuropathy: Natural Remedies & Pain Relief
- Verify Glucometer Accuracy: A Simple Guide for Diabetics
